Who is sponsoring NCT04972617?

NCT04972617 is sponsored by University of Rostock.

What drugs are being tested in NCT04972617?

Interventions in NCT04972617: albumin function analysis (ABIC).

What condition does NCT04972617 study?

NCT04972617 studies Acute Renal Failure, Critical Illness.

Is NCT04972617 still recruiting?

NCT04972617 is currently completed. Last updated 3 November 2022.

Last reviewed 2022-11-03 · How we verify

NCT04972617

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Characterization of the Efficacy of Furosemide Depending on Albumin Function

Completed Last updated 3 November 2022

What this trial tests

trial testing albumin function analysis (ABIC) in Acute Renal Failure in 50 participants. Completed in 31 October 2022.

Timeline

17 May 2022

Primary endpoint
31 October 2022

31 October 2022

Quick facts

Lead sponsor	University of Rostock
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	17 May 2022
Primary completion	31 October 2022
Estimated completion	31 October 2022
Sites	1 location across Germany

Drugs / interventions tested

albumin function analysis (ABIC)

Conditions studied

Acute Renal Failure — all drugs for Acute Renal Failure →
Critical Illness — all drugs for Critical Illness →

Sponsor

University of Rostock

Who can join

18 and older, any sex, with Acute Renal Failure or Critical Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

During this prospective, uncontrolled and non-interventional observational study, the influence of albumin function on the efficacy of furosemide will be investigated. The aim of the study is to provide information on the efficacy of furosemide depending on albumin function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acute Renal Failure

Currently open trials in the same condition.

NCT04334707 — Kidney Precision Medicine Project · recruiting

Other University of Rostock trials

Trials by the same sponsor.

NCT06489470 — Strokectomy in Malignant Cerebral Media Infarction · NA · recruiting
NCT06175429 — Prognostic Value of Exhaled Isoprene Levels for Morbidity and Functional Outcome in Cardiosurgical Patients · unknown
NCT06318208 — Pulmonary Function in Non-hospitalized Adults and Children After Mild COVID-19 · completed
NCT05885620 — SAMi Intervention Study to Evaluate Smartwatch Interventions in Persons With MCI and Dementia · NA · completed
NCT04541602 — Detection of Neuromuscular Complications in Critically Ill Patients · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04972617 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rostock
Last refreshed: 3 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04972617.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing